Cargando…

Ecological Validity of Walking Capacity Tests in Multiple Sclerosis

BACKGROUND: Ecological validity implicates in how far clinical assessments refer to real life. Short clinical gait tests up to ten meters and 2- or 6-Minutes Walking Tests (2MWT/6MWT) are used as performance-based outcomes in Multiple Sclerosis (MS) studies and considered as moderately associated wi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stellmann, J. P., Neuhaus, A., Götze, N., Briken, S., Lederer, C., Schimpl, M., Heesen, C., Daumer, M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4399985/ https://www.ncbi.nlm.nih.gov/pubmed/25879750 http://dx.doi.org/10.1371/journal.pone.0123822

Ejemplares similares

Validating Predictors of Disease Progression in a Large Cohort of Primary-Progressive Multiple Sclerosis Based on a Systematic Literature Review
por: Stellmann, Jan-Patrick, et al.
Publicado: (2014)

Development and Validation of a New Method to Measure Walking Speed in Free-Living Environments Using the Actibelt® Platform
por: Schimpl, Michaela, et al.
Publicado: (2011)

Prognostic Risk Estimates of Patients with Multiple Sclerosis and Their Physicians: Comparison to an Online Analytical Risk Counseling Tool
por: Heesen, Christoph, et al.
Publicado: (2013)

Ecological validity of walking capacity tests following rehabilitation in people with multiple sclerosis
por: Ehling, Rainer, et al.
Publicado: (2019)

Association between Walking Speed and Age in Healthy, Free-Living Individuals Using Mobile Accelerometry—A Cross-Sectional Study
por: Schimpl, Michaela, et al.
Publicado: (2011)

A Web-based tool for personalized prediction of long-term disease course in patients with multiple sclerosis
por: Galea, I, et al.
Publicado: (2013)

Prognosis of the individual course of disease - steps in developing a decision support tool for Multiple Sclerosis
por: Daumer, M, et al.
Publicado: (2007)

Translation and validation of the multiple sclerosis walking scale 12 for the German population – the MSWS-12/D
por: Chorschew, Anna, et al.
Publicado: (2023)

Introducing a new method to assess vision: Computer-adaptive contrast-sensitivity testing predicts visual functioning better than charts in multiple sclerosis patients
por: Stellmann, JP, et al.
Publicado: (2015)

Placebo Cohorts in Phase-3 MS Treatment Trials – Predictors for On-Trial Disease Activity 1990-2010 Based on a Meta-Analysis and Individual Case Data
por: Stellmann, Jan-Patrick, et al.
Publicado: (2012)

The Two-Minute Walk Test in Persons with Multiple Sclerosis: Correlations of Cadence with Free-Living Walking Do Not Support Ecological Validity
por: Karle, Viktoria, et al.
Publicado: (2020)

The 2-minute walk test is not a valid method to determine aerobic capacity in persons with Multiple Sclerosis
por: Beckerman, Heleen, et al.
Publicado: (2019)

Impairment and restrictions in possibly benign multiple sclerosis
por: Schaefer, Laura Melanie, et al.
Publicado: (2019)

Italian Validation of the 12-Item Multiple Sclerosis Walking Scale
por: Solaro, C., et al.
Publicado: (2015)

Smartphone Accelerometry: A Smart and Reliable Measurement of Real-Life Physical Activity in Multiple Sclerosis and Healthy Individuals
por: Zhai, Yuyang, et al.
Publicado: (2020)

Delayed access to conscious processing in multiple sclerosis: Reduced cortical activation and impaired structural connectivity
por: Has Silemek, Arzu C., et al.
Publicado: (2021)

aHSCT is superior to alemtuzumab in maintaining NEDA and improving cognition in multiple sclerosis
por: Häußler, Vivien, et al.
Publicado: (2021)

T1 Relaxation Times in the Cortex and Thalamus Are Associated With Working Memory and Information Processing Speed in Patients With Multiple Sclerosis
por: Thaler, Christian, et al.
Publicado: (2021)

T1w dark blood imaging improves detection of contrast enhancing lesions in multiple sclerosis
por: Thaler, Christian, et al.
Publicado: (2017)

Cognitive performance shows domain specific associations with regional cortical thickness in multiple sclerosis
por: Stellmann, Jan-Patrick, et al.
Publicado: (2021)

Heterogeneity of Multiple Sclerosis Lesions in Multislice Myelin Water Imaging
por: Faizy, Tobias Djamsched, et al.
Publicado: (2016)

T1- Thresholds in Black Holes Increase Clinical-Radiological Correlation in Multiple Sclerosis Patients
por: Thaler, Christian, et al.
Publicado: (2015)

Magnetic Resonance Imaging in Multiple Sclerosis – Patients' Experiences, Information Interests and Responses to an Education Programme
por: Brand, Judith, et al.
Publicado: (2014)

Is multiple sclerosis progression associated with the HLA-DR15 haplotype?
por: Stürner, Klarissa Hanja, et al.
Publicado: (2019)

Functional and structural connectivity substrates of cognitive performance in relapsing remitting multiple sclerosis with mild disability
por: Has Silemek, Arzu Ceylan, et al.
Publicado: (2020)

The natural history of multiple sclerosis, a geographically based study 10: relapses and long-term disability
por: Scalfari, Antonio, et al.
Publicado: (2010)

Increased Perfusion in Normal Appearing White Matter in High Inflammatory Multiple Sclerosis Patients
por: Bester, Maxim, et al.
Publicado: (2015)

Assessing the effect of an evidence-based patient online educational tool for people with multiple sclerosis called UMIMS—understanding magnetic resonance imaging in multiple sclerosis: study protocol for a double-blind, randomized controlled trial
por: Schiffmann, Insa, et al.
Publicado: (2020)

A Two-Minute Walking Test With a Smartphone App for Persons With Multiple Sclerosis: Validation Study
por: van Oirschot, Pim, et al.
Publicado: (2021)

Correction: Increased Perfusion in Normal Appearing White Matter in High Inflammatory Multiple Sclerosis Patients
por: Bester, Maxim, et al.
Publicado: (2015)

Validation of Computer-Adaptive Contrast Sensitivity as a Tool to Assess Visual Impairment in Multiple Sclerosis Patients
por: Rosenkranz, Sina C., et al.
Publicado: (2021)

Heterogeneity of multiple sclerosis lesions in fast diffusional kurtosis imaging
por: Thaler, Christian, et al.
Publicado: (2021)

Short-term MRI measurements as predictors of EDSS progression in relapsing-remitting multiple sclerosis: grey matter atrophy but not lesions are predictive in a real-life setting
por: von Gumberz, Johanna, et al.
Publicado: (2016)

Three weeks of rehabilitation improves walking capacity but not daily physical activity in patients with multiple sclerosis with moderate to severe walking disability
por: Kuendig, Sandra, et al.
Publicado: (2022)

Distinct Functional Connectivity Signatures of Impaired Social Cognition in Multiple Sclerosis
por: Golde, Sabrina, et al.
Publicado: (2020)

Arm Ergometry to Improve Mobility in Progressive Multiple Sclerosis (AMBOS)—Results of a Pilot Randomized Controlled Trial
por: Heinrich, Inga, et al.
Publicado: (2021)

Cognitive Contributors of Backward Walking in Persons with Multiple Sclerosis
por: Takla, Taylor N., et al.
Publicado: (2023)

Evaluation of Prolonged Walking in Persons with Multiple Sclerosis: Reliability of the Spatio-Temporal Walking Variables during the 6-Minute Walk Test
por: Hadouiri, Nawale, et al.
Publicado: (2021)

Reducing the probability of false positive research findings by pre-publication validation – Experience with a large multiple sclerosis database
por: Daumer, Martin, et al.
Publicado: (2008)

Is Walking Capacity in Subjects with Multiple Sclerosis Primarily Related to Muscle Oxidative Capacity or Maximal Muscle Strength? A Pilot Study
por: Hansen, Dominique, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_j37ca6trsi31bsqp15nata8q5r